BeiGene Ltd (BGNE)

(90% Positive) BEIGENE, LTD. (BGNE) Provides Update on access for zanubrutinib (BRUKINSA®) presented at EHA in

Pacira BioSciences Inc (PCRX)

(10% Negative) PACIRA BIOSCIENCES, INC. (PCRX) Announces Delay in million Development Timeline Due to Pandemic-Related Challenges, Manufacturing Considerations, Safety Review, Efficacy Assessment